Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Benzinga

In-Depth Examination Of 17 Analyst Recommendations For Synovus Finl

During the last three months, 17 analysts shared their evaluations of Synovus Finl (NYSE:SNV), revealing diverse outlooks from bullish to bearish.

Forecasting The Future: 19 Analyst Projections For Coterra Energy

Forecasting The Future: 19 Analyst Projections For Coterra Energy

19 analysts have expressed a variety of opinions on Coterra Energy (NYSE:CTRA) over the past quarter, offering a diverse set of opinions from bullish to bearish.

Dell Q3 Earnings Preview: Market Expert Says 'It's All About That Guide'

Dell Q3 Earnings Preview: Market Expert Says 'It's All About That Guide'

Dell Technologies reports Q3 results after market close Tuesday Nov. 26. A look at key items to watch and where shares could go on a strong report.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

A Glimpse Into The Expert Outlook On First Citizens BancShares Through 4 Analysts

In the last three months, 4 analysts have published ratings on First Citizens BancShares (NASDAQ:FCNCA), offering a diverse range of perspectives from bullish to bearish.

LegalZoom.com Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Analysts' ratings for LegalZoom.com (NASDAQ:LZ) over the last quarter vary from bullish to bearish, as provided by 4 analysts.

Critical Insights From Kodiak Gas Services Analyst Ratings: What You Need To Know

9 analysts have expressed a variety of opinions on Kodiak Gas Services (NYSE:KGS) over the past quarter, offering a diverse set of opinions from bullish to bearish.

Critical Insights From Royal Caribbean Gr Analyst Ratings: What You Need To Know

In the last three months, 15 analysts have published ratings on Royal Caribbean Gr (NYSE:RCL), offering a diverse range of perspectives from bullish to bearish.

inkl

Read news from The Economist, FT, and more,
with one subscription

Burlington Stores Faces Warm-Weather Setback, Q3 Revenue Miss Raises Stakes For Holiday Season

Burlington Stores Faces Warm-Weather Setback, Q3 Revenue Miss Raises Stakes For Holiday Season

Burlington Stores reported mixed Q3 results, with revenue missing estimates. CEO confident for Q4 with 0-2% comp sales growth. Q4 outlook: 5-7% sales growth, $3.55-$3.75 EPS. 2024 outlook: 9-10% sales growth, $7.76-$7.96 EPS.

Federal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030

Federal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030

According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%.

AMD Struggles Below Critical Levels: Can Market Share Growth Turn The Tide?

AMD Struggles Below Critical Levels: Can Market Share Growth Turn The Tide?

AMD stock faces bearish wave, below key moving averages with neutral RSI. Short-term rebound possible, but overall technicals and market share gains uncertain.

Archer Aviation Unusual Options Activity For November 26

Archer Aviation Unusual Options Activity For November 26

Investors with a lot of money to spend have taken a bullish stance on Archer Aviation (NYSE:ACHR).

Looking At Celsius Holdings's Recent Unusual Options Activity

Looking At Celsius Holdings's Recent Unusual Options Activity

Investors with a lot of money to spend have taken a bearish stance on Celsius Holdings (NASDAQ:CELH).

Behind the Scenes of Cava Group's Latest Options Trends

Behind the Scenes of Cava Group's Latest Options Trends

Whales with a lot of money to spend have taken a noticeably bearish stance on Cava Group.

Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce

Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce

Alector's AL002 fails in Phase 2 Alzheimer's trial, halting extension study; focus shifts to other programs as workforce is cut by 17%.

Get all your
news in one place.

100’s of premium titles.
One news app.

Under the Radar: From Overlooked to Overperforming - Global Markets Await

We like to look at places that the rest of the world, especially Wall Street and all the instant experts on the Internet, are ignoring.

Bitcoin Correction Could Go As Deep As $88,700 But $125,000 Year-End Target Remains In Play, Says Standard Chartered

Bitcoin‘s (CRYPTO: BTC) sharp pullback from its record high just under $100,000 has sparked concern among traders, with Standard Chartered‘s Geoffrey Kendrick attributing the correction to several factors, including a reduction in U.S.

Cannabinoid Drug For Agitation In Alzheimer's Yields Cognitive Improvements In Clinical Trial

IGC Pharma, Inc.(NYSE:IGC) reported additional interim data from its ongoing Phase 2 clinical trial evaluating IGC-AD1 for agitation in dementia associated with Alzheimer's disease. IGC-AD1 targets neuro-inflammation and CB1 receptor dysfunction,. The investigational drug contains THC as one of two active pharmaceutical agents.

Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs

The Biden Administration's proposal expands Medicare and Medicaid coverage for anti-obesity drugs, cutting costs for millions while addressing the obesity crisis.

Get all your
news in one place.

100’s of premium titles.
One news app.

Nordstrom Q3 Earnings Preview: Can Momentum Continue After Strong Q2 Results?

Nordstrom heads into its Q3 earnings release Tuesday after-hours near 52-week highs following a strong Q2. For the third quarter, analysts will focus on Nordstrom's ability to sustain growth.

Abercrombie & Fitch's Global Growth Powers Q3 Beat, Outlook Raised For 2024

Abercrombie & Fitch Co reports strong Q3 earnings, beating analyst estimates with sales up 14% and EPS of $2.50. Raised full year outlook.

Beyond The Numbers: 4 Analysts Discuss First Hawaiian Stock

First Hawaiian (NASDAQ:FHB) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Assessing Williams Companies: Insights From 11 Financial Analysts

Throughout the last three months, 11 analysts have evaluated Williams Companies (NYSE:WMB), offering a diverse set of opinions from bullish to bearish.

Expert Ratings For First Horizon

First Horizon (NYSE:FHN) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

Comparative Study: Amazon.com And Industry Competitors In Broadline Retail Industry

In today's rapidly changing and fiercely competitive business landscape, it is vital for investors and industry enthusiasts to carefully evaluate companies. In this article, we will perform a comprehensive industry comparison, evaluating Amazon.com (NASDAQ:AMZN) against its key competitors in the Broadline Retail industry. By analyzing important financial metrics, market position,…

Assessing Meta Platforms's Performance Against Competitors In Interactive Media & Services Industry

Amidst today's fast-paced and highly competitive business environment, it is crucial for investors and industry enthusiasts to conduct comprehensive company evaluations. In this article, we will delve into an extensive industry comparison, evaluating Meta Platforms (NASDAQ:META) in comparison to its major competitors within the Interactive Media & Services industry. By…

1 … 61 62 63 64

People

Michael OSullivan

David Chiaverini

Lars Fruergaard Jørgensen

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Alzheimer Disease

Places

247,712 stories

The United States

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play